Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, 2023. Verfasst von Richard Gammon und 10 weiteren Autor:innen. Beteiligte Einrichtung: OneBlood, Scientific, Medical, Technical Direction, Orlando, Florida, USA. Hauptthemen laut MEDLINE: Blood Component Transfusion, Blood Component Removal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
The demand for blood products sometimes exceeds the available inventory. Blood product inventories are dependent upon the availability of donors, supplies and reagents, and collection staff. During prolonged extreme shortages, blood centers and transfusion services must alter practices to meet the needs of patients. Study Design and Methods The Association for the Advancement of Blood and Biotherapies Donor and Blood Component Management Subsection compiled some strategies from its blood center and hospital transfusion service members that could be implemented during blood product shortages.
Results
Some strategies that blood centers could use to increase their available inventories include increasing donor recruitment efforts, using alternate types of collection kits, manufacturing low‐yield apheresis‐derived platelets and/or whole blood‐derived platelets, using cold−stored platelets, transferring inventory internally among centers of the same enterprise, using frozen inventory, decreasing standing order quantities, prioritizing allocation to certain patient populations, filling partial orders, and educating customers and blood center staff. Transfusion service strategies that could be implemented to maximize the use of the limited available inventory include increasing patient blood management efforts, using split units, finding alternate blood suppliers, trading blood products with other hospital transfusion services, developing a patient priority list, assembling a hospital committee to decide on triaging priorities, using expired products in extreme situations, and accepting nonconforming products after performing safety checks.
Discussion
Blood centers and transfusion services must choose the appropriate strategies to implement based on their needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- OneBlood, Scientific, Medical, Technical Direction, Orlando, Florida, USA.
- Department of Pathology and Laboratory Medicine; Blood Bank and Therapeutic Apheresis Unit, Roswell Park Comprehensive Cancer Center, and Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Scien…
- Ontario Regional Blood Coordinating Network, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Vanderbilt University Medical Center (VUMC), Nashville, Tennessee, USA.
- Department of Transfusion Medicine, Mohandai Oswal Hospital, Ludhiana, India.
- Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
ORCID-Profile: Richard Gammon, Divjot Singh Lamba, Shaughn Nalezinski, Jorge Rios, Yvette C Tanhehco
Zitieren
APA
Gammon, R., Becker, J., Cameron, T., Eichbaum, Q., Jindal, A., Lamba, D. S., Nalezinski, S., Rios, J., Shaikh, S., Shepherd, J., & Tanhehco, Y. C. (2023). How do I manage a blood product shortage?. Transfusion. https://doi.org/10.1111/trf.17572
Vancouver
Gammon R, Becker J, Cameron T, Eichbaum Q, Jindal A, Lamba DS, et al. How do I manage a blood product shortage?. Transfusion. 2023. doi:10.1111/trf.17572
BibTeX
@article{Gammon2023,
author = {Gammon, Richard and Becker, Joanne and Cameron, Tracy and Eichbaum, Quentin and Jindal, Aikaj and Lamba, Divjot Singh and Nalezinski, Shaughn and Rios, Jorge and Shaikh, Salima and Shepherd, Janine and Tanhehco, Yvette C},
title = {How do I manage a blood product shortage?},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17572}
}
EUVIMED